These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 12089954)
21. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Hernandez JD; Wesseling K; Salusky IB Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350 [TBL] [Abstract][Full Text] [Related]
22. [Renal osteodystrophy (3); its treatment in dialysis patients]. Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385 [TBL] [Abstract][Full Text] [Related]
23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
24. The renal bone diseases in children treated with dialysis. Sanchez CP; Salusky IB Adv Ren Replace Ther; 1996 Jan; 3(1):14-23. PubMed ID: 8620364 [TBL] [Abstract][Full Text] [Related]
25. Renal osteodystrophy: review of the disease and its treatment. El-Kishawi AM; El-Nahas AM Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):373-82. PubMed ID: 16970258 [TBL] [Abstract][Full Text] [Related]
32. [Therapy for ROD and measurement of the bone mass]. Yamamoto I; Kawamura Y; Hirano K; Hayakawa H; Shigematu T Clin Calcium; 2004 Dec; 14(12):83-8. PubMed ID: 15577179 [TBL] [Abstract][Full Text] [Related]
33. [Chronic kidney disease-mineral and bone disorder (CKD-MBD)]. Hamada Y; Fukagawa M Nihon Rinsho; 2006 Sep; 64(9):1703-6. PubMed ID: 16972683 [TBL] [Abstract][Full Text] [Related]
34. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. Christiansen P APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of new markers of bone metabolism in renal osteodystrophy in children]. Deschenes G; Souberbielle JC; Brunelle F; Dechaux M Ann Pediatr (Paris); 1990 Feb; 37(2):120-2. PubMed ID: 2181914 [TBL] [Abstract][Full Text] [Related]
37. The effects of calcium and phosphorus in hemodialysis. Goldsmith RS Annu Rev Med; 1976; 27():181-90. PubMed ID: 180871 [TBL] [Abstract][Full Text] [Related]
38. PTH(1-84)/PTH(7-84): a balance of power. Friedman PA; Goodman WG Am J Physiol Renal Physiol; 2006 May; 290(5):F975-84. PubMed ID: 16601298 [TBL] [Abstract][Full Text] [Related]
39. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. Torres PU J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031 [TBL] [Abstract][Full Text] [Related]
40. Recent advances in the management of renal osteodystrophy in children. Salusky IB; Ramirez JA; Goodman WG Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):580-7. PubMed ID: 7859020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]